Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes : a systematic review and meta-analysis

dc.contributor.author	Leitão, Cristiane Bauermann	pt_BR
dc.contributor.author	Pinto, Lana Catani Ferreira	pt_BR
dc.contributor.author	Rados, Dimitris Rucks Varvaki	pt_BR
dc.contributor.author	Remonti, Luciana Loss Reck	pt_BR
dc.contributor.author	Viana, Marina Verçoza	pt_BR
dc.contributor.author	Gross, Jorge Luiz	pt_BR
dc.date.accessioned	2018-09-27T02:34:18Z	pt_BR
dc.date.issued	2018	pt_BR
dc.identifier.issn	2446-5321	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/182847	pt_BR
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	Archives of endocrinology and metabolism suplement. São Paulo	pt_BR
dc.rights	Open Access	en
dc.subject	Medicina	pt_BR
dc.title	Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes : a systematic review and meta-analysis	pt_BR
dc.type	Resumo publicado em evento	pt_BR
dc.contributor.event	Congresso Brasileiro de Endocrinologia e Metabologia (33. : 2018 : Belo Horizonte, MG)	pt_BR
dc.identifier.nrb	001077258	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License